Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Occidental Petroleum
OXY
5
Louisiana-Pacific
LPX
US OptionsDetailed Quotes
RARE250516P22500
- 0.00
- 0.000.00%
15min DelayClose May 9 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest22.50Strike Price0.00Turnover0.00%IV35.92%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier6DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma35.11Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Ultragenyx Pharmaceutical Newsroom
Ultragenyx Pharma Is Maintained at Overweight by Morgan Stanley
Ultragenyx Pharmaceutical Analyst Ratings
Morgan Stanley Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Raises Target Price to $65
A Quick Look at Today's Ratings for Ultragenyx Pharmaceutical(RARE.US), With a Forecast Between $39 to $110
Truist Financial Remains a Buy on Ultragenyx Pharmaceutical (RARE)
Barclays Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Maintains Target Price $81
TD Cowen Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Maintains Target Price $86
Ultragenyx Pharmaceutical: Promising Developments and Strategic Progress Drive Buy Rating
Barclays Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Maintains Target Price $81
BofA Securities Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Maintains Target Price $80
BofA Securities Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Cuts Target Price to $80
BofA Adjusts Price Target on Ultragenyx Pharmaceutical to $80 From $83, Keeps Buy Rating
Wedbush Maintains Ultragenyx Pharmaceutical(RARE.US) With Hold Rating, Cuts Target Price to $39
Truist Financial Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating
J.P. Morgan Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Raises Target Price to $117
Ultragenyx Pharma Is Maintained at Overweight by JP Morgan
Ultragenyx Pharmaceutical Analyst Ratings
Piper Sandler Initiates Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Announces Target Price $115
Ultragenyx Pharmaceutical (RARE) Gets a Buy From Piper Sandler
Morgan Stanley Initiates Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Announces Target Price $64
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
